Research programme: cancer therapeutics - UnibioscreenAlternative Names: UNBS 3243
Latest Information Update: 01 Apr 2009
At a glance
- Originator Unibioscreen
- Class Fluoroquinolones
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Research Cancer
Most Recent Events
- 26 Mar 2009 Preclinical development is ongoing in Belgium
- 18 Sep 2007 Early research in Cancer in Belgium (unspecified route)